These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 24463816)

  • 21. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [
    Li X; Li N
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):177-181. PubMed ID: 31106535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia activated long non-coding RNA HABON regulates the growth and proliferation of hepatocarcinoma cells by binding to and antagonizing HIF-1 alpha.
    Ma CN; Wo LL; Wang DF; Zhou CX; Li JC; Zhang X; Gong XF; Wang CL; He M; Zhao Q
    RNA Biol; 2021 Nov; 18(11):1791-1806. PubMed ID: 33478328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linc-ROR drive adriamycin resistance by targeting AP-2α/Wnt/β-catenin axis in hepatocellular carcinoma.
    Shi CJ; Lv MY; Deng LQ; Zeng WQ; Fu WM; Zhang JF
    Cell Biol Toxicol; 2023 Aug; 39(4):1735-1752. PubMed ID: 36576707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression.
    Mo J; Li B; Zhou Y; Xu Y; Jiang H; Cheng X; Wu X; Zhang Y
    Biomed Pharmacother; 2019 Dec; 120():109403. PubMed ID: 31562977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells.
    Tak E; Jun DY; Kim SH; Park GC; Lee J; Hwang S; Song GW; Lee SG
    J Int Med Res; 2016 Dec; 44(6):1234-1247. PubMed ID: 27807254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
    Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
    Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of
    Huang YH; Lian WS; Wang FS; Wang PW; Lin HY; Tsai MC; Yang YL
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long noncoding RNA
    Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
    J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
    Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
    World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/ERK pathway.
    He H; Chen T; Mo H; Chen S; Liu Q; Guo C
    Biochem Biophys Res Commun; 2020 Dec; 533(4):886-892. PubMed ID: 33008585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway.
    Kung-Chun Chiu D; Pui-Wah Tse A; Law CT; Ming-Jing Xu I; Lee D; Chen M; Kit-Ho Lai R; Wai-Hin Yuen V; Wing-Sum Cheu J; Wai-Hung Ho D; Wong CM; Zhang H; Ng IO; Chak-Lui Wong C
    Cell Death Dis; 2019 Dec; 10(12):934. PubMed ID: 31819034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
    Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
    [No Abstract]   [Full Text] [Related]  

  • 38. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2.
    Gao H; Wang T; Zhang P; Shang M; Gao Z; Yang F; Liu R
    J Cell Physiol; 2020 Mar; 235(3):2325-2335. PubMed ID: 31541467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review on the importance of LINC-ROR in human disorders.
    Ghafouri-Fard S; Pourtavakoli A; Hussen BM; Taheri M; Kiani A
    Pathol Res Pract; 2023 Apr; 244():154420. PubMed ID: 36989849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway.
    Bai L; Zhuang Y; Xie J; Liu K; Yin S; Yan F
    Biochem Genet; 2023 Jun; 61(3):1113-1127. PubMed ID: 36451051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.